Company: DMAAR
Filing Date: 2025-01-30
Form Type: 8-K
Source: 0001213900-25-008377
Chunk: 2

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-01-30
Form: 8-K
Item: Item 3.02
Chunk 2
---
Item 3.02. Unregistered
Sales of Equity Securities.

Simultaneously with the
closing of the IPO, the Company consummated the private placement (“ Private Placement”) with the Sponsor of 400,000 units
(the “ Private Units”) at a price of $10.00 per Private Unit, generating total proceeds of $4,000,000.

The Private Units are
identical to the Units sold in the IPO except with respect to certain registration rights and transfer restrictions,
as described in the Registration Statement. Additionally, the holders of the Private Units have agreed to certain restrictions on the
Private Units, as described in the Registration Statement. Additionally, such holders agreed not to transfer, assign or sell any of the
Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until the earlier to occur of: (i) with respect to 50% of the Private Units, the earlier of six months after the date
of the consummation of the initial business combination and the date on which the closing price of the ordinary shares equals or exceeds
$12.50 per share (as adjusted for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any
20 trading days within any 30-trading day period commencing after the initial business combination and (ii) with respect to the remaining
50% of the Private Units, six months after the date of the consummation of the initial business combination, or earlier, in either case,
if, subsequent to the initial business combination, the Company consummates a liquidation, merger, share exchange or other similar transaction
which results in all of its shareholders having the right to exchange their ordinary shares for cash, securities or other property. The holders were granted certain demand and piggyback registration
rights in connection with the purchase of the Private Units.

The Private Units were
issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transaction did not involve a public offering.

Item 5.03. Amendments
to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

On January 7, 2025, and
in connection with the IPO, the Company adopted its Second Amended and Restated Memorandum and Articles of Association. The Second Amended
and Restated Memorandum and Articles of Association is filed herewith as Exhibit 3.1 and is incorporated by reference herein.

Item 8.01